美国 · 平台与数据 · Morningstar
Novartis Raises Guidance After Trial Setbacks Hit Profit
Novartis raised its full-year earnings guidance, citing solid sales growth and productivity gains, even as recent clinical-trial setbacks hit the Swiss drugmaker's bottom line in…
在 Morningstar 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.morningstar.com)
